This page shows the latest Enerzair Breezhaler news and features for those working in and with pharma, biotech and healthcare.
Asthma treatment received EU approval earlier this week. Novartis has published the full results from the phase 3 IRIDIUM study of its Enerzair Breezhaler in patients with uncontrolled asthma. ... The overall occurrence of adverse events and serious
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Novartis entered a partnership with Propeller to utilise the company’s sensor for the Enerzair Breezhaler inhaler, where it can collect medication data and send that information to a corresponding app.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...